EKF Diagnostics (EKF) Competitors

EKF Diagnostics (LON:EKF) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

Do institutionals and insiders believe in EKF or NIOX?

50.0% of EKF Diagnostics shares are held by institutional investors. Comparatively, 7.6% of NIOX Group shares are held by institutional investors. 39.4% of EKF Diagnostics shares are held by company insiders. Comparatively, 4.9% of NIOX Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Is EKF or NIOX more profitable?

NIOX Group has a net margin of 28.21% compared to EKF Diagnostics' net margin of 9.37%. NIOX Group's return on equity of 13.29% beat EKF Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EKF Diagnostics	9.37%	7.03%	5.27%
NIOX Group	28.21%	13.29%	3.95%

Does the media refer more to EKF or NIOX?

In the previous week, NIOX Group had 1 more articles in the media than EKF Diagnostics. MarketBeat recorded 2 mentions for NIOX Group and 1 mentions for EKF Diagnostics. NIOX Group's average media sentiment score of 1.21 beat EKF Diagnostics' score of 0.00 indicating that NIOX Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EKF Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
NIOX Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings and valuation, EKF or NIOX?

NIOX Group has lower revenue, but higher earnings than EKF Diagnostics. EKF Diagnostics is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EKF Diagnostics	£50.22M	2.78	£4.68M	£0.01	2,299.26
NIOX Group	£46M	6.72	£995.88M	£0.01	5,922.00

Do analysts rate EKF or NIOX?

NIOX Group has a consensus target price of GBX 90, suggesting a potential upside of 21.58%. Given NIOX Group's stronger consensus rating and higher probable upside, analysts clearly believe NIOX Group is more favorable than EKF Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility and risk, EKF or NIOX?

EKF Diagnostics has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Comparatively, NIOX Group has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500.

Summary

NIOX Group beats EKF Diagnostics on 11 of the 16 factors compared between the two stocks.